June 12, 2017 – Med Alliance announced completion on schedule of patient enrollment in the first-in-man (FIM) study of SELUTION, a novel sirolimus-coated balloon. The 50 patient study enrolled between October 2016 and May 23, 2017 across four German centers: Franziskus Krankenhaus, Berlin; Evangelisches Krankenhaus Hubertus, Berlin; Vivantes Klinikum Neukölln, Berlin; and Universitäts-Herzzentrum, Bad Krozingen.

June 12, 2017 — Heart muscle is one of the least renewable tissues in the body, which is one of the reasons that heart disease is the leading cause of death for both men and women in the United States, according to the Centers for Disease Control and Prevention. Inspired by the idea of helping the heart repair itself, researchers at Baylor College of Medicine and the Texas Heart Institute have studied pathways known to be involved in heart cell functions and discovered a previously unknown connection between processes that keep the heart from repairing itself.

June 12, 2017 – The Medtronic Resolute Onyx Drug-Eluting Stent (DES) met its primary endpoint of target lesion failure (TLF) at one year for the treatment of coronary artery disease in extra-small vessels. Results from the RESOLUTE ONYX 2.0 mm Clinical Study were presented today as a late-breaking trial session at the 2017 EuroPCR annual meeting and simultaneously published in the Journal of the American College of Cardiology (JACC): Cardiovascular Intervention.